Total Funding
63
68
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
63069
Tolerion is a biotechnology company addressing the cause of autoimmune diseases through bio-therapeutic.
- Graeme Currie: Chief Development OfficerPast Role: Rainier Therapeutics, COO
- Larry Steinman: Founder and Executive Chairman
About the Company
Tolerion is a biotechnology company addressing the cause of autoimmune diseases through bio-therapeutic. They use our novel antigen-specific immune tolerance induction platform to engineer product candidates that restore balance in autoimmune conditions in which self-antigens (or “autoantigens”) incite a destructive immune response.
Tolerion was
founded in 2001 and is headquartered in South San Francisco, California, USA.
